GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Cyclically Adjusted Book per Share

Moberg Pharma AB (OSTO:MOB) Cyclically Adjusted Book per Share : kr150.44 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Moberg Pharma AB's adjusted book value per share for the three months ended in Sep. 2024 was kr19.889. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr150.44 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Moberg Pharma AB's average Cyclically Adjusted Book Growth Rate was -5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-12-15), Moberg Pharma AB's current stock price is kr10.28. Moberg Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was kr150.44. Moberg Pharma AB's Cyclically Adjusted PB Ratio of today is 0.07.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Moberg Pharma AB was 3.34. The lowest was 0.03. And the median was 0.11.


Moberg Pharma AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Moberg Pharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Cyclically Adjusted Book per Share Chart

Moberg Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 148.18 162.25 159.21

Moberg Pharma AB Quarterly Data
Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.95 159.21 156.72 154.32 150.44

Competitive Comparison of Moberg Pharma AB's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Cyclically Adjusted PB Ratio falls into.



Moberg Pharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Moberg Pharma AB's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=19.889/132.3043*132.3043
=19.889

Current CPI (Sep. 2024) = 132.3043.

Moberg Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201409 118.045 100.161 155.928
201412 123.839 100.225 163.477
201503 136.469 99.950 180.644
201506 134.950 99.995 178.554
201509 140.367 100.228 185.289
201512 141.267 100.276 186.388
201603 137.183 100.751 180.146
201606 151.630 101.019 198.589
201609 158.326 101.138 207.116
201612 183.616 102.022 238.118
201703 181.362 102.022 235.195
201706 174.906 102.752 225.210
201709 175.995 103.279 225.456
201712 180.303 103.793 229.832
201803 182.371 103.962 232.090
201806 186.688 104.875 235.516
201809 189.302 105.679 236.996
201812 191.004 105.912 238.601
201903 358.928 105.886 448.479
201906 0.000 106.742 0.000
201909 372.077 107.214 459.152
202003 101.427 106.563 125.928
202006 0.000 107.498 0.000
202009 98.030 107.635 120.498
202012 0.000 108.296 0.000
202103 65.051 108.360 79.426
202106 64.462 108.928 78.296
202109 63.965 110.338 76.699
202112 63.433 112.486 74.609
202203 62.313 114.825 71.799
202206 36.647 118.384 40.956
202209 36.374 122.296 39.351
202212 36.199 126.365 37.900
202303 35.893 127.042 37.380
202306 35.668 129.407 36.467
202309 22.057 130.224 22.409
202312 21.842 131.912 21.907
202403 21.631 132.205 21.647
202406 20.271 132.716 20.208
202409 19.889 132.304 19.889

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Moberg Pharma AB  (OSTO:MOB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Moberg Pharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.28/150.44
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Moberg Pharma AB was 3.34. The lowest was 0.03. And the median was 0.11.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Moberg Pharma AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB Business Description

Industry
Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.